The role of DPYD and the effects of DPYD suppressor luteolin combined with 5‐FU in pancreatic cancer

The role of DPYD and the effects of DPYD suppressor luteolin combined with 5‐FU in pancreatic cancer

Abstract Background Despite advances in the treatment of cancer, pancreatic ductal adenocarcinoma (PDAC) remains highly lethal due to the lack of effective therapies. Our previous study showed that Luteolin (Lut), a flavonoid, suppressed pancreatocarcinogenesis and reduced the expression of dihydrop...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hiroyuki Kato, Motonori Sato, Aya Naiki‐Ito, Shingo Inaguma, Makoto Sano, Masayuki Komura, Yuko Nagayasu, Kuang Xiaochen, Akihisa Kato, Yoichi Matsuo, Hideaki Ijichi, Satoru Takahashi
Format:	Article
Language:	English
Published:	Wiley 2024-08-01
Series:	Cancer Medicine
Subjects:	5‐fluorouracil combination drug therapy dihydropyrimidine dehydrogenase luteolin pancreatic cancer
Online Access:	https://doi.org/10.1002/cam4.70124
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol
by: Cassandra White, et al.
Published: (2024-11-01)

DPYD variant testing in candidates for fluoropyrimidine treatment: A study protocol
by: Ana Hernández-Guío, et al.
Published: (2021-05-01)

Anti-Graying Effects of External and Internal Treatments with Luteolin on Hair in Model Mice
by: Machiko Iida, et al.
Published: (2024-12-01)

Identifying a Novel DPYD Polymorphism Associated with Severe Toxicity to 5-FU Chemotherapy in a Saudi Patient
by: Nedal Bukhari, et al.
Published: (2019-01-01)

Mediator effect of luteolin on electrooxidation of NADH
by: Gulshat Gylyjova, et al.
Published: (2021-04-01)

Effects of Luteolin Treatment on Postharvest Quality and Antioxidant Capacity of Nanfeng Tangerines
by: Wenjuan Dong, et al.
Published: (2024-12-01)

Implementation of DPYD testing in Bulgarian patients with cancer
by: Nelly Miteva-Marcheva, et al.
Published: (2024-12-01)

Role of Plant Phytochemicals: Resveratrol, Curcumin, Luteolin and Quercetin in Demyelination, Neurodegeneration, and Epilepsy
by: Mikołaj Grabarczyk, et al.
Published: (2024-11-01)

Extraction, detection, bioactivity, and product development of luteolin: A review
by: Fajian Ren, et al.
Published: (2024-12-01)

Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases
by: Jialian Lv, et al.
Published: (2025-02-01)

The potential role of luteolin, a flavonoid in cancer prevention and treatment
by: Hajed Obaid A Alharbi, et al.
Published: (2024-12-01)

Luteolin alleviates cerebral ischemia/reperfusion injury by regulating cell pyroptosis
by: Yu Fei, et al.
Published: (2024-11-01)

Luteolin detoxifies DEHP and prevents liver injury by degrading Uroc1 protein in mice
by: Huiting Wang, et al.
Published: (2024-10-01)

Recent Developments in Luteolin-Loaded Nanoformulations for Enhanced Anti-Carcinogenic Activities: Insights from In Vitro and In Vivo Studies
by: Muhammad Redza Fahmi Mod Razif, et al.
Published: (2024-10-01)

Clinical impact of DPYD genotyping and dose adjustment in candidates for fluoropyrimidine treatment
by: Ana Hernández-Guío, et al.
Published: (2024-12-01)

Luteolin improves mitochondrial dynamics and function in ulcerative colitis via the miR-195-5p/Notch signalling pathway
by: Moxixuan Liu, et al.
Published: (2025-01-01)

Ultrasonic-assisted extraction of luteolin from peanut shells using ionic liquid and its molecular mechanism
by: Liwei Niu, et al.
Published: (2025-02-01)

Lentinan's effect on gut microbiota and inflammatory cytokines in 5-FU-induced mucositis mice
by: Xiaoxiao Zhang, et al.
Published: (2025-01-01)

Aerosol Inhalation of Luteolin-7-O-Glucuronide Exerts Anti-Inflammatory Effects by Inhibiting NLRP3 Inflammasome Activation
by: Jianliang Li, et al.
Published: (2024-12-01)

Rutin and luteolin purified from Gerbera jamesonii and Chrysanthemum ‘dante purple’ flowers exert remarkable protection against the enteropathogen, E. coli O78, in poultry
by: Shaimaa Negm El-Dein, et al.
Published: (2024-11-01)

Influence of DPYD Genetic Polymorphisms on 5-Fluorouracil Toxicities in Patients with Colorectal Cancer: A Meta-Analysis
by: Qiang Li, et al.
Published: (2014-01-01)

Retracted: Influence of DPYD Genetic Polymorphisms on 5-Fluorouracil Toxicities in Patients with Colorectal Cancer: A Meta-Analysis
by: Gastroenterology Research and Practice
Published: (2020-01-01)

The Frequency of <i>DPYD</i> c.557A>G in the Dominican Population and Its Association with African Ancestry
by: Mariela Guevara, et al.
Published: (2024-12-01)

Optimization of Extraction of Luteolin from <i>Schisandra chinensis</i> by Ionic Liquid–Enzyme Complex System and Antioxidant Study Analysis
by: Jingwei Hao, et al.
Published: (2024-12-01)

Clinical implications of a gain-of-function genetic polymorphism in DPYD (rs4294451) in colorectal cancer patients treated with fluoropyrimidines
by: Elena De Mattia, et al.
Published: (2024-12-01)

Anti-diabetic potential of apigenin, luteolin, and baicalein via partially activating PI3K/Akt/Glut-4 signaling pathways in insulin-resistant HepG2 cells
by: Lingchao Miao, et al.
Published: (2023-11-01)

Nucleotide metabolism-associated drug resistance gene NDUFA4L2 promotes colon cancer progression and 5-FU resistance
by: Hongxin HE, et al.
Published: (2025-01-01)

FOXC1-mediated serine metabolism reprogramming enhances colorectal cancer growth and 5-FU resistance under serine restriction
by: Zhukai Chen, et al.
Published: (2025-01-01)

Mechanism of Qingjie Fuzheng Granules on alleviating 5-FU chemotherapy-induced intestinal mucositis in a mouse model of Colorectal Cancer by regulating Cathepsin B/NLRP3 pathway
by: Yuan Yingfei, et al.
Published: (2024-01-01)

Current best evidence in pigmentary dermatology
by: Priyansh Gupta, et al.
Published: (2024-05-01)

Novel NO-TZDs and trimethoxychalcone-based DHPMs: design, synthesis, and biological evaluation as potential VEGFR-2 inhibitors
by: Mater H. Mahnashi, et al.
Published: (2024-12-01)

Pharmacogenetic‐guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC‐PGx): A multicenter clinical trial
by: Sarah Glewis, et al.
Published: (2024-12-01)

Discrimination of Farming Practices Through Olive Leaf Phenolic and Mineral Analysis
by: Mario Franić, et al.
Published: (2024-12-01)

Efficient in-situ synthesis of heterocyclic derivatives from benzyl alcohols using pyrazinium chlorochromate-functionalized carbonitride as a novel catalyst
by: Hasan Soltani, et al.
Published: (2024-10-01)

Design, synthesis and biological Evaluation of novel chromones having 3,4-dihydropyrimidin-2(1H)-one core at C-8 in combination with triazoles: New α-glucosidase inhibitors and anti-bacterial agents
by: Kumara Swamy Taviti, et al.
Published: (2024-12-01)

5-Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan as a Potential Standard for Second-line Therapy in Extrapulmonary Neuroendocrine Carcinomas
by: I-Wei Ho, et al.
Published: (2024-12-01)

Effects of <i>Tithonia diversifolia</i> Extract as a Feed Additive on Digestibility and Performance of Hair Lambs
by: Olga Teresa Barreto-Cruz, et al.
Published: (2024-12-01)

Ultrasound-assisted extraction of peanut shell by-product: Chemical properties, antioxidant, and anti-inflammatory effects
by: Kang Jung Wook, et al.
Published: (2024-01-01)

Exploring the efficacy of fluorouracil and platinum based chemotherapy in advanced hepatocellular carcinoma to bridge the treatment gap in resource limited settings
by: Se Jun Park, et al.
Published: (2025-01-01)

Combination Therapy of 5-Fluorouracil and Triamcinolone Acetonide with Compression Therapy after Surgical Excision in the Management of Keloids in Ears
by: Randeep Singh Lamba, et al.